Cargando…
CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells
SIMPLE SUMMARY: Squamous cell carcinoma is a type of cancer resulting from cancer of the squamous cells that line some organs of the body such as the skin, lungs, and vulva. It is one of the leading causes of cancer-related deaths worldwide. In the current study, we show that a protein called CD109...
Autores principales: | Zhou, Shufeng, Hassan, Amani, Kungyal, Tenzin, Tabariès, Sebastien, Luna, José Luis Ramírez García, Siegel, Peter M., Philip, Anie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367592/ https://www.ncbi.nlm.nih.gov/pubmed/35954339 http://dx.doi.org/10.3390/cancers14153672 |
Ejemplares similares
-
CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro
por: Zhou, Shufeng, et al.
Publicado: (2019) -
CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-β-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma
por: Zhou, Shufeng, et al.
Publicado: (2017) -
CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma
por: Mo, Xue-Tang, et al.
Publicado: (2020) -
CD109 and squamous cell carcinoma
por: Qi, Ruixia, et al.
Publicado: (2018) -
CD109 expression is upregulated in penile squamous cell carcinoma
por: Dong, Fengyun, et al.
Publicado: (2017)